Finance

Lists
Why is JAGSNPHARM down 2,16%?
Dive Deeper
JAGSNPHARM:NSE
Jagsonpal Pharmaceuticals Ltd
219,01 ₹
-2,16%
(-4,84) 1D
15 қаз., 15:30:01 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for JAGSNPHARM...
Open
224,60 ₹
High
224,60 ₹
Low
218,20 ₹
Mkt. cap
14,47 млрд
Avg. vol.
419,89 м.
Volume
44,52 мың
Dividend
1,14%
Quarterly dividend
0,63 ₹
Ex-dividend date
2026 ж. 04 қыр.
P/E ratio
32,53
52-wk high
264,50 ₹
52-wk low
155,00 ₹
EPS
6,73 ₹
Shares outstanding
26,20 млн
No. of employees
1 мың
Open
224,60 ₹
High
224,60 ₹
Low
218,20 ₹
Mkt. cap
14,47 млрд
Avg. vol.
419,89 м.
Volume
44,52 мың
Dividend
1,14%
Quarterly dividend
0,63 ₹
Ex-dividend date
2026 ж. 04 қыр.
P/E ratio
32,53
52-wk high
264,50 ₹
52-wk low
155,00 ₹
EPS
6,73 ₹
Shares outstanding
26,20 млн
No. of employees
1 мың
News stories
From web sources and news partners
About Jagsonpal Pharmaceuticals Ltd
CEO-
Employees1,3 мың
Founded1978
Headquarters-
SectorPharmaceutical industry
Last report
2026 ж. 30 шіл.
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
822,32 млн / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
744,65 млн
729,45 млн
642,03 млн
822,32 млн
Cost of goods sold
272,28 млн
264,53 млн
249,67 млн
286,24 млн
Cost of revenue
272,28 млн
264,53 млн
249,67 млн
286,24 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
165,46 млн
172,95 млн
397,81 млн
227,78 млн
Operating expense
331,89 млн
326,10 млн
303,96 млн
385,10 млн
Total operating expenses
604,17 млн
590,63 млн
553,63 млн
671,34 млн
Operating income
140,48 млн
138,82 млн
88,40 млн
150,98 млн
Other non operating income
30,27 млн
29,75 млн
-87,71 млн
28,33 млн
EBT including unusual items
168,10 млн
145,21 млн
117,56 млн
176,80 млн
EBT excluding unusual items
168,10 млн
166,00 млн
117,56 млн
176,80 млн
Income tax expense
42,36 млн
35,70 млн
29,94 млн
44,91 млн
Effective tax rate
25,20%
24,59%
25,47%
25,40%
Other operating expenses
126,28 млн
126,45 млн
-82,94 млн
135,90 млн
Net income
125,74 млн
109,51 млн
87,62 млн
131,89 млн
Net profit margin
16,89%
15,01%
13,65%
16,04%
Earnings per share
-
-
-
-
Interest and investment income
-
-
117,43 млн
-
Interest expense
-2,65 млн
-2,57 млн
-560,00 м.
-2,51 млн
Net interest expenses
-2,65 млн
-2,57 млн
116,87 млн
-2,51 млн
Depreciation and amortization charges
23,86 млн
23,86 млн
23,19 млн
21,42 млн
EBITDA
164,18 млн
155,55 млн
108,00 млн
174,59 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары